Genome-wide analysis of DNA methylation identifies S100A13 as an epigenetic biomarker in individuals with chronic (≥ 30 years) type 2 diabetes without diabetic retinopathy.
Tao LiYi XuYongyong ShiJianhua ChenSenlin LinJianfeng ZhuXian XuLina LuHai-Dong ZouPublished in: Clinical epigenetics (2020)
DMSs in the S100A13 gene may be potential biomarkers of DR.